Home

The team at Adelaide Enterprise deliver university technologies to the market that create a positive impact on society and in turn bring benefits to the University to support its research activities and ongoing innovation.

Current opportunities

Search our technology portfolio for your next big idea.

Resources

We assist you to protect technologies, develop products and services and make your ideas investment ready.

Results

The positive outputs of our commercial ventures have provided further research funding and made a positive impact around the world.

Intellectual Property management

Need help with understanding the ins and outs of IP? Find out everything you need to know here.

Commercial opportunities

We are actively seeking commercial partners. Find out about our featured opportunities.

Adelaide Biodesign

Applications for the 2019 Adelaide Biodesign course are now open!

News

20

May

University of Adelaide's own Leabrook Barley variety shaping up to be Cooper's "malt of choice"

Bred by the University of Adelaide at its Waite Institute, WI4896 has been named Leabrook having passed stage 1 malt accreditation in March. It will become an accredited malting variety in March 2020 if it passes Stage 2 this year.

22

Jan

GPN Vaccines raises AUD$1.1 million

GPN Vaccines, a vaccine development company focussed on the prevention of diseases caused by the world’s foremost bacterial pathogen, Streptococcus pneumoniae, has raised AUD$1.1 million (USD$0.8 million) towards development of its proprietary vaccine, Gamma-PNTM.

21

Jan

New blood test detects early stage Ovarian Cancer

Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer - a disease which kills over 1000 Australian women and 150,000 globally each year.

more...

Connect with us

Connect with Adelaide Enterprise on Social Media.

Keep up to date with events, funding opportunities and other commercialisation and IP resources.